# CHAMPION-1 (NCT01677858)

> A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01677858
- Phase: PHASE1, PHASE2
- Status: COMPLETED
- Sponsor: Amgen
- Conditions: Multiple Myeloma
- Interventions: Carfilzomib; Dexamethasone
- Enrollment: 116
- Primary outcome: Phase 1: Number of Participants With Dose-limiting Toxicities (DLTs)
- Primary outcome: Overall Response Rate (ORR)

## Indexed commentary on CHAMPION-1 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=champion-1-nct01677858